Getting the message out

Relaxed medicine advertising guidelines are set to boost downscheduling applications, industry believes Recent reforms to advertising regulations for Schedule 3 medicines are a "big win" for consumers, pharmacy and industry, and could lead to more downscheduling requests, ASMI believes. Speaking at APP2018 on the Gold coast, Lindsay Forrest, Chair of the Australian Self Medication Industry (ASMI)